The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated•Originally published 27 April 2026•Updated 29 April 2026•

1 min read

Viavi and Bio-Techne Q3 Earnings Preview: Focus on AI and Biotech Momentum

Key Facts

1VIAV is preparing to report its Q3 earnings with a focus on revenue growth drivers.

2The company rolled out new hollow core fiber testing, XEdge upgrades, and 1.6T TestCenter D2.

3The company is targeting AI data centers and 5G networks with its new product offerings.

Viavi Solutions Inc. (VIAV) is preparing to report its third-quarter financial results, with investors focusing on AI data center solutions and 5G infrastructure as primary growth drivers. Simultaneously, Bio-Techne (TECH) is set to release its Q3 results, with expectations for modest revenue growth fueled by improving biotech funding trends and strong product momentum. Viavi continues to leverage its expanded portfolio, including the 1.6T TestCenter D2, to capture demand in high-growth digital sectors. Meanwhile, analysts are closely monitoring Bio-Techne's ability to capitalize on the recovery in life sciences investment. Both companies are positioned at the intersection of technological innovation and market recovery, making their upcoming reports critical for sector sentiment. These earnings calls will provide essential insights into the financial health of the network testing and biotechnology industries.

about 1 month ago

Version History

Version 1about 1 month ago

What changed: The story was updated to include Q3 earnings expectations for Bio-Techne alongside Viavi, focusing on biotech funding trends and product momentum.